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Dear Sir,
The term ‘heart attack’, inclusive of Acute Coronary Syndromes
(ACS) and myocardial infarction (MI) is based on symptoms,
Electrocardiographic (ECG) abnormalities and biomarkers. In an
attempt to engage laypeople and non-experts, the term ‘kidney
attack’ has been introduced to refer to Acute Kidney Injury (AKI) [1].
Acute kidney injury is a clinical syndrome associated with increased
morbidity and mortality making early recognition critical in patient
management. The consensus definition of AKI is based on changes
in serum Creatinine (sCr) or urine output (UO) [2]. However, it has
been long recognized that perturbations in sCr and UO can be induced
by pathophysiologic processes that do not cause injury (e.g. volume
depletion); just as cardiac output can be decreased by pathophysiologic
process unrelated to cardiac ischemia (e.g. bradycardia or volume
depletion). Similar to the approach used to differentiate ST-segment
elevation myocardial infarction (STEMI) from non-ST-segment
elevation myocardial infarction (NSTEMI), a new classification schema
of AKI has been proposed. With the advent of robust novel AKI
biomarkers, subclinical AKI (a rise in novel AKI biomarkers alone) is
analogous to an NSTEMI, while clinical AKI (a rise in AKI biomarkers
and significant perturbation in SCr or UO) is analogous to STEMI [3,4].
In patients with ACS, cardiac angina is a symptom complex that

Standard definition for all spectrum of myocardial ischemia/threat or “Heart
Attack” are well established9-14. With the advent of diagnostic tools predominately
biomarkers the definitions of “Heart Attack” has also evolved9. Similarly with
the kidneys, the advent of renal injury biomarkers call for a new paradigm in
AKI or “Kidney Attack”. The lack of symptoms and delays in conventional AKI
markers highlight a greater impetus for this term “Kidney Attack” within such a
framework as we have highlighted. It is also stressed that injury and function
in the renal and cardiac sense or not synonymous. In addition physiological
differences highlight that injury is not always associated with loss of function
and vice versa. It is thus important we introduce the term “attack” to categorize
stages of heightened risk that may or may not be associated with early renal
functional decline.
Bio = cardiac or renal biomarkers; EF = ejection fraction , surrogate for cardiac
function; EKGST = electrocardiogram ST segment; MI = myocardial injury/
infarction; N = Normal; RF = Renal Function; RI = renal injury/infarction; ST
segments; Th = Thrombus; Sym = symptom; UO = urine output; ↑ increased; ↓
= decreased; ↓ = Trend; + = positive; - negative; ± equivocal
Figure 1: Proposed umbrella lay terms ‘heart attack’ and ‘kidney attack’ with
parallel clinical syndromes.
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prompts care, is well codified, and helps clinicians assess pre-test
probability for integration into diagnostic testing (i.e. a supportive
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Two clinical pathways are shown. Chest pain pathways are well established.
Renal pathways are less well established. Urine output and SCr provide surrogate
information on renal function. With the advent of AKI biomarkers, clinicians now
have the ability to anticipate renal injury, with or without functional changes, as
early as 2 hours from the insult. With more specific and comprehensive renal
injury and function information we also begin the paradigm of reclassification the
spectrum of “acute kidney syndromes”. We have chosen the term “Kidney Attack”
as it highlights firstly the urgency involved and secondly there are correlations with
the lessons learnt from the heart. We emphasize that the role of AKI biomarkers
are still partly in the research domain, and so to our understanding of “acute
kidney syndromes”. As such the schema proposed, has a degree of conjecture,
however we feel that significant impetus is needed to highlight renal injury risks
and as such the severity of the “Kidney Attack”. We have chosen NGAL from the
spectrum of renal biomarkers as it remains the most likely candidate for a “Renal
Troponin”. Renal injury biomarkers have a broader pathogenic base than serum
troponin, for those discussion we point readers initially to Ref 15. (Diagram and
concepts modified from ref 14, 15).
ABBREVIATIONS: AKI = acute kidney injury; ECG = electrocardiogram; EF
= ejection fraction , surrogate for cardiac function. EKG = electrocardiogram;
NGAL = neutrophil gelatinase associated lipocalin; NSTEMI = non ST elevation
myocardial infarction; ST segments; STEMI = ST elevation myocardial infarction;
Sym = symptom; UAP = unstable angina pectoris; UO = urine output;
SYMBOLS: ↑ increased; ↓ = decreased; ↑ = Trend; + = positive; - negative; ±
equivocal; ∆ = changes; ↑ + range from equivocal to positive
Figure 2: Established chest pain pathway for ‘heart attack’ and proposed kidney
injury pathway for ‘kidney attack’.
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history for ACS). Because AKI does not cause visceral discomfort,
the concept of Renal Angina (RA) or pathophysiologic stress on the
kidneys, the parallel of cardiac angina, has been introduced in order to
provide a similar construct to help direct the use and interpretation of
AKI diagnostics [5]. Renal angina is currently undergoing validation in
prospective studies of adults and children.
Thus, a new nomenclature for ‘kidney attack’ and AKI related
syndromes with a wider spectrum of clinical criteria (clinical AKI,
subclinical AKI, and renal angina) could be used for classification
purposes (Figure 1 and Figure 2) [6-12]. The parallels between the
terminology used in ACS and AKI is intentional, as we hope to use
these familiar and accessible terms to help teach the non-experts how to
appropriately integrate these new terms into the clinical vernacular. The
public health burden of AKI is substantial. The population incidence of
AKI is approximately 2,100 per million population and the case fatality
rate is 25-50% [6]. Given the population of the developed world (USA,
Canada, Western Europe, Japan, and Australia) of approximately 1
billion, there will be over 2 million cases of AKI this year, with 500,000
associated deaths and an expected 1.5 million AKI survivors. Of these
patients, approximately 15-20% will progress to advanced stage CKD
within 24 months, resulting in 300,000 cases of advanced CKD per
year. With the increasing incidence of AKI in the aging population, the
projected incidence of CKD associated with AKI is expected to increase
[7,8].
In conclusion, the advances in consensus definitions and diagnostic
biomarkers in AKI have led to an evolution in the nomenclature
of the syndrome. Similar to the progress made in ACS and the lay
term ‘heart attack’, AKI and ‘kidney attack’ hold promise. We believe
that an educational campaign for awareness and alertness should be
undertaken to prevent and improve early recognition of ‘kidney attack’
with use of novel, approved biomarkers and careful assessment of urine
output. We think that the new terminology centered around ‘kidney
attack’ will provide uniformity in the public health approach to AKI,
and help to reveal what has been neglected and underestimated for too
long simply because it was not clinically detectable.
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